(RTTNews) - Treace Medical Concepts ... risk of nickel allergy reactions associated with traditional nitinol staples. It also supports the healing process with a unique fixation method that ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...

announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation ...

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional ...

2025 Outlook Treace plans to provide 2025 financial guidance during its fourth quarter 2024 earnings conference call, which is currently scheduled for Thursday, February 27, 2025, at 4:30 p.m ...

Treace Medical Concepts, Inc. has announced the limited market release of its new Percuplasty™ Percutaneous 3D Bunion Correction® System, following successful initial surgical cases. This ...

PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company ...

Fintel reports that on December 31, 2024, Lake Street initiated coverage of Treace Medical Concepts (NasdaqGS:TMCI) with a Buy recommendation. Analyst Price Forecast Suggests 14.53% Upside As of ...

Treace, CEO, Founder and Board Member of Treace ... the potential for nickel allergy reaction associated with nitinol staples. SpeedPlate™ technology is a gamechanger for my Lapiplasty ...